Stevanato Group S.p.A (STVN) Non Operating Interest Expenses (2020 - 2026)
Stevanato Group S.p.A's (STVN) quarterly Non Operating Interest Expenses came in at $2.3 million in Q2 2026, down 82.23% year-over-year from $13.0 million in Q2 2025, and down 30.94% quarter-over-quarter from $3.3 million in Q1 2026.
Analysis
Stevanato Group S.p.A (STVN) Non Operating Interest Expenses (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Non Operating Interest Expenses for 7 consecutive years, with $2.3 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non Operating Interest Expenses fell 82.23% year-over-year to $2.3 million in Q2 2026; TTM through Jun 2026 was $15.8 million, a 46.95% decrease from a year earlier, with the FY2025 full-year figure at $26.4 million, up 72.07% from the prior year.
- Non Operating Interest Expenses was $2.3 million for Q2 2026 at Stevanato Group S.p.A, down from $3.3 million in the prior quarter.
- Over five years, Non Operating Interest Expenses peaked at $13.0 million in Q2 2025 and troughed at $2.3 million in Q2 2026.
- A 5-year average of $6.4 million and a median of $5.9 million in 2023 frame the typical range for Non Operating Interest Expenses.
- Across the five-year window, Non Operating Interest Expenses jumped 405.7% in 2025 and plunged 82.23% in 2026, its largest moves.
- Over 5 years, Non Operating Interest Expenses stood at $7.2 million in 2022, then jumped by 41.11% to $10.2 million in 2023, then dropped by 18.46% to $8.3 million in 2024, then tumbled by 35.76% to $5.4 million in 2025, then tumbled by 56.89% to $2.3 million in 2026.
- The last three Non Operating Interest Expenses figures came in at $2.3 million (Q2 2026), $3.3 million (Q1 2026), and $5.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 49.65 Bn | 48.78 Bn | 2.32 Bn | 132.00 Mn |
| 2 | Medline | 29.30 Bn | 26.62 Bn | 2.22 Bn | - |
| 3 | West Pharmaceutical Services | 24.04 Bn | 23.60 Bn | 329.20 Mn | 2.60 Mn |
| 4 | Baxter International | 12.78 Bn | 10.63 Bn | 1.03 Bn | - |
| 5 | Stevanato Group S.p.A | 5.53 Bn | 5.42 Bn | 100.91 Mn | 2.31 Mn |
| 6 | Acme United | 234.28 Mn | 229.24 Mn | 26.69 Mn | - |
| 7 | Rockwell Medical | 28.82 Mn | 4.02 Mn | 3.24 Mn | 281,000.00 |
| 8 | Retractable Technologies | 20.96 Mn | -18.91 Mn | 190,852.00 | 18,705.00 |
| 9 | United Health Products | 9.59 Mn | 9.56 Mn | - | 50,456.00 |
| 10 | Cuprina Holdings (Cayman) | 8.14 Mn | 5.02 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.31 Mn |
| Mar 31, 2026 | 3.34 Mn |
| Dec 31, 2025 | 5.35 Mn |
| Sep 30, 2025 | 4.75 Mn |
| Jun 30, 2025 | 12.99 Mn |
| Mar 31, 2025 | 5.76 Mn |
| Dec 31, 2024 | 8.34 Mn |
| Sep 30, 2024 | 2.61 Mn |
| Jun 30, 2024 | 2.57 Mn |
| Mar 31, 2024 | 2.48 Mn |
| Dec 31, 2023 | 10.22 Mn |
| Sep 30, 2023 | 6.07 Mn |
| Jun 30, 2023 | 7.93 Mn |
| Mar 31, 2023 | 9.66 Mn |
| Dec 31, 2022 | 7.24 Mn |
| Sep 30, 2022 | 8.32 Mn |
| Jun 30, 2022 | 10.53 Mn |
| Mar 31, 2022 | 5.18 Mn |
| Dec 31, 2021 | 5.83 Mn |
| Sep 30, 2021 | 9.47 Mn |